Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.43 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.43 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.43 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 9/20 | 0.38 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.35 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.35 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.33 |
| ▸ | TK2 | O00142 | 1/20 | 0.33 |
| ▸ | TK1 | P04183 | 1/20 | 0.33 |
| ▸ | DUT | P33316 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10697841 | 0.91 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2242410 | 0.90 | SLC28A1 (0.44) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL29101322 | 0.89 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL8345024 | 0.86 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL27879786 | 0.86 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL9670017 | 0.86 | SLC28A1 (0.41) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL8099831 | 0.85 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL95904 | 0.84 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL15285199 | 0.84 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL7866086 | 0.84 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116284186-A | Cyanine fluorescent marker, synthesis method and application thereof | 北京超精核酸科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| US-9963696-B2 | Method for screening mutant microorganism overproducing target metabolite using synthetic suicide genetic circuit | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2018-05-08 | — | — | US | claimed |
| US-20150376610-A1 | METHOD FOR SCREENING MUTANT MICROORGANISM OVERPRODUCING TARGET METABOLITE USING SYNTHETIC SUICIDE GENETIC CIRCUIT | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2015-12-31 | — | — | US | claimed |
| EP-0642363-B1 | USE OF HYDROGELS TO FIX BONE REPLACEMENTS | M U R S T BR ITALIAN MINISTRY (IT) | 2001-10-04 | — | — | EP | claimed |
| EP-0197718-B2 | New medicaments for topical use | FIDIA SPA (IT) | 2001-07-25 | — | — | EP | claimed |
| EP-0792369-B1 | SUICIDE GENES AND COMBINATIONS OF PYRIMIDINE NUCLEOSIDE AND NUCLEOBASE ANALOGUES WITH SUICIDE GENES FOR GENE THERAPY | CAYLA (FR) | 2000-04-05 | — | — | EP | claimed |
| US-5856153-A | AN EUKARYOTIC VECTOR CONTAINING TWO EXPRESSION SUCIDE GENE UNITS, FIRST UNIT SENSITIZES TUMOR CELLS TO 5-FLUOROCYTOSINE AND SECOND EXPRESSION SUCIDE GENE UNIT SENSITIZES A MAMMAL CELL OR HIV-INFECTED CELLS TO AZIDOTHYMIDINE NUCLEOSIDE | CAYLA (FR) | 1999-01-05 | — | — | US | claimed |
| EP-0831794-A4 | ACYCLOVIR DERIVATIVES FOR TOPICAL USE | HOSTETLER KARL Y (US) | 1998-11-04 | — | — | EP | claimed |
| EP-0831794-A1 | ACYCLOVIR DERIVATIVES FOR TOPICAL USE | HOSTETLER, Karl Y. (US) | 1998-04-01 | — | — | EP | claimed |
| EP-0792369-A1 | SUICIDE GENES AND COMBINATIONS OF PYRIMIDINE NUCLEOSIDE AND NUCLEOBASE ANALOGUES WITH SUICIDE GENES FOR GENE THERAPY | CAYLA (FR) | 1997-09-03 | — | — | EP | claimed |
| US-5645592-A | COATED ON ORTHOPEDIC FASTENERS | M.u.r.s.t. Italian Ministry for Universities and Scientific and Technological Research (IT) | 1997-07-08 | — | — | US | claimed |
| WO-1996040088-A1 | ACYCLOVIR DERIVATIVES FOR TOPICAL USE | HOSTETLER KARL Y (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996016183-A1 | SUICIDE GENES AND COMBINATIONS OF PYRIMIDINE NUCLEOSIDE AND NUCLEOBASE ANALOGUES WITH SUICIDE GENES FOR GENE THERAPY | CAYLA (FR) | 1996-05-30 | — | — | WO | claimed |
| US-5442053-A | Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions | FIDIA, S.P.A. (IT) | 1995-08-15 | — | — | US | claimed |
| EP-0642363-A1 | USE OF HYDROGELS TO FIX BONE REPLACEMENTS | M.U.R.S.T. ITALIAN MINISTRY FOR UNIVERSITY AND SCIENTIFIC AND TECHNOLOGICAL RESEARCH (IT) | 1995-03-15 | — | — | EP | claimed |
| EP-0197718-B1 | New medicaments for topical use | FIDIA SPA (IT) | 1993-12-15 | — | — | EP | claimed |
| WO-1993023094-A1 | USE OF HYDROGELS TO FIX BONE REPLACEMENTS | M.U.R.S.T., ITALIAN MINISTRY FOR UNIVERSITIES AND SCIENTIFIC AND TECHNOLOGICAL RESEARCH (IT) | 1993-11-25 | — | — | WO | claimed |
| EP-0260428-A2 | Cationic surfactants and pharmaceutical compositions containing them | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-23 | — | — | EP | claimed |
| CN-120118841-A | Composition, induction method and application of chemical reprogramming induction functional ciRPE cells | 瓯江实验室 | 2025-06-10 | — | — | CN | disclosed |
| EP-0103783-A2 | Dermatological preparation | Dr. Thilo & Co. GmbH (DE) | 1984-03-28 | — | — | EP | disclosed |